Zaldyon

Generic name:mesalamine
Dosage form: tablet, delayed release

Medically reviewed by Drugs.com. Last updated on Feb 1, 2022.

Indications and Usage for Zaldyon

Zaldyon is indicated for the treatment of moderately active ulcerative colitis in adults.

Limitations of Use:

Safety and effectiveness of Zaldyon beyond 6 weeks have not been established.

Zaldyon Dosage and Administration

2.1 Important Administration Instructions

• Do not substitute one Zaldyon 800 mg tablet for two mesalamine delayed-release 400 mg oral products [see Clinical Pharmacology (12.3)].
• Evaluate renal function prior to initiation of Zaldyon.
• Take Zaldyon tablets on an empty stomach, at least 1 hour before and 2 hours after a meal [see Clinical Pharmacology (12.3)] .
• Swallow Zaldyon tablets whole. Do not cut, break or chew the tablets.
• Drink an adequate amount of fluids [see Warnings and Precautions (5.7)].
• Intact, partially intact, and/or tablet shells have been reported in the stool; Instruct patients to contact their healthcare provider if this occurs repeatedly.
• Protect Zaldyon tablets from moisture. Close the container tightly and leave desiccant pouches in the bottle along with the tablets.

Dosage Information

For the treatment of moderately active ulcerative colitis, the recommended dosage of Zaldyon in adults is 1600 mg (two 800 mg tablets) three times daily (total daily dosage of 4.8 grams) for a duration of 6 weeks.

Dosage Forms and Strengths

Zaldyon (mesalamine) delayed-release tablets are available as reddish-brown colored, capsule-shaped, biconvex, enteric coated tablets imprinted with "435" on one side and plain on other side.

Contraindications